Kaiser Permanente, Mass Normal again Windfall spinoff DexCare’s $50M collection B spherical
DexCare, the digital care working system that was spun out of Windfall Well being final March, has raised $50 million in collection B funding for its platform that manages well being system capability and demand.
Windfall Well being’s Digital Innovation Group initially developed the DexCare platform in 2016 to assist affected person acquisition and navigation. Now, the factitious intelligence-driven platform offers these companies to a number of well being techniques.
Transformation Capital led the collection B spherical, with participation from Kaiser Permanente, Windfall Ventures, Mass Normal Brigham, Outline Ventures, Frist Cressey Ventures and SpringRock Ventures.
“Hospitals are transferring to hybrid care and wish a single resolution to draw new sufferers and to attach them each nearly and in-person with their very own caregivers,” stated Derek Streat, co-founder and CEO of DexCare, in a assertion. “This funding will assist us speed up platform growth and go-to-market progress for our rising variety of premier well being techniques similar to Kaiser Permanente, Windfall, Mass Normal Brigham, CHS, Houston Methodist and others. Transformation Capital’s digital well being focus will assist us obtain these objectives together with our present line-up of prime healthcare-focused companions.”
DexCare’s platform hyperlinks a number of digital well being functions to satisfy affected person wants with real-time demand aggregation and accessible appointment reserving throughout service strains like same-day and pressing care, in addition to throughout care modalities from in-person to digital care.
The know-how presents an answer to the rising demand for consumer-facing well being tech in response to COVID-19, which requires interoperable working techniques that may present personalised and cost-effective care, the corporate stated.
The Seattle-based firm raised $21 million in its collection A spherical, bringing its whole funding to $71 million in lower than a yr.
The collection B funding will assist DexCare speed up their product and know-how growth, in addition to assist their buyer expertise and recruit new expertise, the corporate stated.
“DexCare was important in digitally reworking our ambulatory care mannequin to higher serve the wants of sufferers and was additionally a key a part of Windfall’s digital response to COVID,” stated Aaron Martin, government vice chairman and chief digital officer at Windfall. “We’re excited that the platform incubated by the Digital Innovation Group, and that has added a lot worth to Windfall over a number of years, is seeing such an enthusiastic reception from different well being techniques. We’re trying ahead to the improvements the DexCare staff will ship to prospects because of this newest fundraise.”
Windfall’s Digital Innovation Group helps the event of applied sciences that reply to healthcare issues, sometimes constructing the product themselves.
DexCare is the third health-related enterprise to have spun out from the group, following Xealth and Circle, each developed internally at Windfall.
Digital prescribing platform Xealth launched independently in 2017, and ladies’s well being platform Circle was acquired by Wildflower Well being in 2018.
Windfall additionally collaborated with different main well being techniques final February to launch Truveta, which swimming pools affected person information for analysis and drug growth. Tenet Well being, CommonSpirit Well being, Creation Well being and Northwell Well being are among the many 14 whole companions contributing to the startup.
